Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with Duchenne muscular dystrophy

Journal of Physiology

Volumn 589, Issue 9, 2011, Pages 2161-2170

  Lawler, John M ^a  

^a Texas A M University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; CAVEOLIN 3; CORTICOSTEROID; CYCLOSPORIN A; DEFLAZACORT; DYSTROPHIN; EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PENICILLAMINE; PREDNISONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STREPTOMYCIN; TOCOPHEROL;

BREATHING MUSCLE; CONFERENCE PAPER; CYTOSKELETON; DIAPHRAGM MUSCLE; DISEASE PREDISPOSITION; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; GROWTH DISORDER; HUMAN; IMMUNE DEFICIENCY; INFLAMMATION; IRON RESTRICTION; LEG MUSCLE; LOCOMOTION; MUSCLE INJURY; MUSCLE WEAKNESS; MYOFIBROSIS; NONHUMAN; OSTEOPENIA; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RISK FACTOR; SIDE EFFECT; UPREGULATION; WEIGHT GAIN;

ANIMALS; CAVEOLIN 3; DYSTROGLYCANS; HUMANS; INFLAMMATION MEDIATORS; MOTOR ACTIVITY; MUSCLE CONTRACTION; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; NADPH OXIDASE; NF-KAPPA B; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RESPIRATORY MUSCLES; SIGNAL TRANSDUCTION; TRPC CATION CHANNELS;

EID: 79955462126     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.207456     Document Type: Conference Paper

References (104)

1. Abrogast S, Smith J, Matuszczak JY, Hardin BJ, Moylan JS, Smith JD et al (2007). Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice. J Appl Physiol 102, 956-964.
2. Adams V, Jiang H, Yu J, Möbius-Winkler S, Fiehn E, Linke A et al (1999). Apoptosis in skeletal muscle myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol 33, 959-965.
3. Aggarwal BB and Shishodia S (2004). Suppression of the nuclear factor-κB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 1030, 434-441.
4. Alexakis C, Partridge T, Bou-Gharios G (2007). Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am J Physiol Cell Physiol 293, C661-C669.
5. Allen DG, Gervasio OL, Yeung EW and Whitehead NP (2010). Calcium and the damage pathways in muscular dystrophy. Can J Physiol Pharmacol 88, 83-91.
6. Anderson JE, Weber M and Vargas C (2000). Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy. Cell Transplant 9, 551-564.
7. Bernardi P (1999). Mitochondria in muscle cell death. Ital J Neurol Sci 20, 395-400.
8. Binder HJ, Herting DC, Hurst V, Finch SC and Sprio HM (1965). Tocopherol deficiency in man. N Engl J Med 273, 1289-1297.
9. Bomman L, Rossouw H, Gericke GS and Polla BS (1998). Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy. Biochem Pharmacol 56, 751-757.
10. Bonafati MD, Ruzza G, Bonometto P, Bernardinelli A, Gorni K, Orcesi S, Lanzi G and Angelini C (2000). A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve 23, 1344-1347.
11. Bouchentouf M, Benabdallah BF and Tremblay JP (2004). Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation 77, 1349-1356.
12. Buck M and Chojkier M (1996). Muscle wasting and dedifferentiation induced by oxidative stress in a model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 15, 1753-1765.
13. Buetler TM, Renard M, Offord EA, Schneider H and Ruegg UT (2002). Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am J Clin Nutr 75, 749-753.
14. Carter GT and McDonald CM (2000). Preserving function in Duchenne dystrophy with long-term pulse prednisone therapy. Am J Phys Med Rehabil 79, 455-458.
15. Childers MK, Okamura CS, Bogan DJ, Bogan JR, Petroski GF, McDonald K and Kornegay JN (2002). Eccentric contraction injury in dystrophic canine muscle. Arch Phys Med Rehabil 83, 1572-1578.
16. Compton AG, Cooper ST, Hill PM, Yang N, Froehner SC and North KN (2005). The syntrophin-dystrobrevin subcomplex in human neuromuscular disorders. J Neuropathol Exp Neurol 64, 350-361.
17. Crépieux P, Kwon H, Leclerc N, Spencer W, Richard S, Lin R and Hiscott J (1997). IκBα physically interacts with a cytoskeleton-associated protein through its signal response domain. Mol Cell Biol 17, 7375-7385.
18. Criswell DS (2004). Trolox attenuates mechanical ventilation-induced contractile Suppl.
19. Dalla-Libera L, Sabbadini R, Renken C, Ravara B, Sandri M, Betto R et al (2001). Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-α and sphingosine. J Mol Cell Cardiol 33, 1871-1878.
20. DeLuca A, Nico B, Liatonio A, Didonna MP, Fraysse B, Pierno S, Burdi R, Mangieri D, Rolland JF, Camerino C, Zallone A, Confalonieri P, Andreetta F, Arnoldi E, Courdier-Fruh I, Magyar JP, Frigeri A, Pisoni M, Svelto M and Camerino DC (2005). A mulitidisciplinary evaluation of the effectiveness of cyclosporine A in dystrophic mdx mice. Am J Pathol 166, 477-489.
21. Disatnik M-H and Rando TA (1999). Integrin-mediated muscle cell spreading. J Biol Chem 274, 32486-32492.
22. Escolar DM and Scacheri CG (2001). Pharmacologic and genetic therapy for childhood muscular dystrophies. Curr Neurol Neurosci Rep 1, 168-174.
23. Evans NP, Misyak SA, Robertson JL, Bassaganya-Riera J, Robert W and Grange RW (2010). Immune-mediated mechanisms potentially regulate the disease time course of Duchenne muscular dystrophy and provide targets for therapeutic intervention. PM R 1, 755-768.
24. Fecchi K, Volonte D, Hezel MP, Schmeck K and Galbiati F (2006). Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells. FASEB J 20, 705-707.
25. Fenichel GM, Brooke MH, Griggs RC, Mendell JR, Miller JP, Moxley RT 3rd et al (1988). Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E. Muscle Nerve 11, 1164-1168.
26. Fanin M, Tasca E, Nascimbeni AC and Angelini C (2009). Sarcolemmal neuronal nitric oxide synthase defect in limb-girdle muscular dystrophy: an adverse modulating factor in the disease course? J Neuropathol Exp Neurol 68, 383-390.
27. Fisher AB (2009). Redox signaling across cell membranes. Antioxid Redox Signal 11, 1349-1356.
28. Galbiati F, Razani B and Lisanti MP (2001). Caveolae and caveolin-3 in muscular dystrophy. Trends Mol Med 7, 435-441.
29. Gervásio OL, Whitehead NP, Yeung EW, Phillips WD and Allen DG (2008). TRPC1 binds to caveolin-3 and is regulated by Src kinase - role in Duchenne muscular dystrophy. J Cell Sci 121, 2246-2255.
30. Girgenrath M, Dominov JA, Kostek CA and Miller JB (2004). Inhibition of apoptosis improves outcome in a model of congential muscular dystrophy. J Clin Invest 114, 1635-1639.
31. Gius D, Botero A, Shah S and Curry HA (1999). Intracellular oxidation/reduction status in the regulation of transcription factors NF-kB and AP-1. Toxicol Lett 106, 93-106.
32. Gosselin LE and Martinez DA (2004). Impact of TNF-α blockade on TGF-β1 and type I collagen mRNA expression in dystrophic muscle. Muscle Nerve 30, 244-246.
33. Gosselin LE, Martinez DA, Vailas AC and Sieck GC (1994). Passive length-force properties of senescent diaphragm: relationship with collagen characteristics. J Appl Physiol 76, 2680-2685.
34. Grinio LP, Orlov ON, Prilipko LL and Kagan VE (1984). Lipid peroxidation in children with Duchenne's hereditary myopathy (in Russian). Biull Eksp Biol Med 98, 423-425.
35. Hartel JV, Granchelli JA, Hudecki MS, Pollina CM and Gosselin LE (2001). Impact of prednisone on TGF-β1 and collagen in diaphragm muscle from mdx mice. Muscle Nerve 24, 428-432.
36. Ichiyanagi T, Hatano Y, Matsuo S and Konishi T (2004). Simultaneous comparison of relative reactivities of twelve major anthocyanins in bilberry towards reactive nitrogen species. Chem Pharm Bull 52, 1312-1315.
37. Jarrett BW and Foster JL (1999). Alternative binding of actin and calmodulin to multiple sites on dystrophin. J Biol Chem 270, 5578-5586.
38. Jones KJ, Compton AG, Yang N, Mills MA, Peters MF, Mowat D et al (2003). Deficiency of the syntrophins and a-dystrobrevin in patients with inherited myopathy. Neuromuscul Disord 13, 456-467.
39. Kameya S, Miyagoe Y, Nonaka I, Ikemoto T, Endo M, Hanaoka K, Nabeshima Y and Takeda S (1999). α1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration. J Biol Chem 274, 2193-2200.
40. Kassiri Z and Khokha R (2005). Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors. Thromb Haemost 93, 212-219.
41. Kim HB (2009). Effect of the catalase/superoxide dismutase mimetic EUK-134 on damage, inflammation, and force generation on the diaphragm muscle of mdx mice. Doctoral Dissertation, Texas AandM University
42. Kosek D and Bamman M (2008). Modulation of the dystrophin-associated protein complex in response to resistance training in young and older men. J Appl Physiol 104, 1476-1484.
43. Kumar A and Boriek AM (2003). Mechanical stress activates nuclear factor-κB pathway in skeletal muscle fibres: a possible role in Duchenne muscular dystrophy. FASEB J 17, 386-396.
44. Kumar A, Takada Y, Boriek AM and Aggarwal BB (2004). Nuclear factor-kB: its role in health and disease. J Mol Med 82, 434-448.
45. Kwak HB, Kim JH and Lawler JM (2008). NAD(P)H oxidase inhibition upregulates anti-apoptotic BAG-4 protein expression in the mdx diaphragm. FASEB J 22, 959.8 (abstract).
46. Lawler JM, Song W and Demaree SR (2003). Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle. Free Rad Biol Med 35, 9-16.
47. Lawler JM, Song W and Kwak HB (2006). Differential regulation of heat shock proteins by hindlimb unloading and reloading in the rat soleus. Muscle Nerve 33, 200-207.
48. Li H, Mittal A, Makonchuk DY, Bhatnagar S and Kumar A (2009). Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Hum Mol Genet 18, 2584-2598.
49. Lim JH, Kim DY and Bang MS (2004). Effects of exercise and steroid on skeletal muscle apoptosis in the mdx mouse. Muscle Nerve 30, 456-462.
50. Lund TC, Grange RW and Lowe DA (2007). Telomere shortening in diaphragm and tibialis anterior muscles of aged mdx mice. Muscle Nerve 36, 387-390.
51. Marzetti E, Privitera G, Simili V, Wohlgemuth SE, Aulisa L, Pahor M and Leeuwenburgh C (2010). Multiple pathways to the same end: mechanisms of myonuclear apoptosis in sarcopenia of aging. Sci World J 10, 340-349.
52. McClung JM, Kavazis AN, DeRuisseau KC, Falk DJ, Deering MA, Lee Y, Sugiura T and Powers SK (2007). Caspase-3 regulation of diaphragm myonuclear domain during mechanical ventilation-induced atrophy. Am J Respir 175, 150-159.
53. Messina S, Bitto A, Aguennouz M, Minutoli L, Monici MC, Altavilla D, Squadrito F and Vita G (2006). Nuclear factor κ-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Exp Neurol 198, 234-241.
54. Mikhailov YM, Kroptov AV, Zelenin AV, Krutilina RI, Kolesnikov VA, Zelenina IA et al (2002). The Bcl-xL and ACR-1 genes promote differentiation and reduce apoptosis in muscle fibers of mdx mice (in Russian). Genetika 38, 1445-1450.
55. Monici MC, Aguennouz M, Mazzeo A, Messina C and Vita G (2003). Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 60, 993-997.
56. Muller FL, Song W, Liu Y, Chaudhuri A, Pieke-Dahl S, Strong R et al (2006). Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic Biol Med 40, 1993-2004.
57. Nakae Y, Stoward PJ, Shono M and Matsuzaki T (2001). Most apoptotic cells in mdx diaphragm muscle contain accumulated lipofuscin. Histochem Cell Biol 115, 205-214.
58. Nakamura A and Takeda S (2011). Mammalian models of duchenne muscular dystrophy: pathological characteristics and therapeutic applications. J Biomed Biotechnol 2011, 184393.
59. Nakae Y, Stoward PJ, Shono M, and Matsuzaki T (2001). Most apoptotic cells in mdx diaphragm muscle contain accumulated lipofuscin. Histochem. Cell Biol 115, 205-214.
60. phox reduces muscle membrane lysis during muscle inflammation in mice. J Physiol 553, 833-841.
61. Percival JM, Anderson KN, Gregorevic P, Chamberlain JS and Froehner SC (2008). Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice. PLoS One 3, e3387.
62. Pescatori M, Broccolini A, Minetti C, Bertini E, Bruno C, D'amico A et al (2007). Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J 21, 1210-1226.
63. Peterson JM, Kline W, Canan BD, Ricca DJ, Kaspar B, Delfín DA et al (2011). Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy. Mol Med DOI
64. Powers SK, Kavazis AN and McClung JM (2007). Oxidative stress and disuse muscle atrophy. J Appl Physiol 102, 2389-2397.
65. Puttini S, Lekka M, Dorchies OM, Saugy D, Incitti T, Ruegg UT et al (2009). Gene-mediated restoration of normal myofiber elasticity in dystrophic muscles. Mol Ther 17, 19-25.
66. Ramaswamy KS, Palmer ML, van der Meulen JH, Renoux A, Kostrominova TY, Michele DE and Faulkner JA (2011). Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats. J Physiol DOI
67. Rando TA (2001). The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in muscular dystrophies. Muscle Nerve 24, 1575-1594.
68. Rando TA, Disatnik MH, Yu Y and Franco A (1998). Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul Disord 8, 14-21.
69. Rice KM, Preston DL, Neff D, Norton M and Blough ER (2006). Age-related dystrophin-glycoprotein complex structure and function in the rat extensor digitorum longus and soleus muscle. J Gerontol A Biol Sci Med Sci 11, 1119-1129.
70. Roelofs RI, de Arango GS, Law PK, Kinsman D, Buchanan DC and Park JH (1979). Treatment of Duchenne's muscular dystrophy with penicillamine. Results of a double-blind trial. Arch Neurol 36, 266-268.
71. Rousseau J, Dumont N, Lebel C, Quenneville SP, Côté CH, Frenette J and Tremblay JP (2010). Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage. Cell Transplant 19, 589-596.
72. Sandri M, El Meslemani AH, Sandri C, Schierling P, Vissing K, Andersen JL et al (2001). Caspase-3 expression correlates with skeletal muscle apoptosis in Duchenne and vacioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J Neuropath Exp Neurol 60, 302-312.
73. Sandri M and Carraro U (1999). Apoptosis of skeletal muscle during development and disease. Int J Biochem Cell Biol 21, 1373-1390.
74. Senf SM, Dodd SL, McClung JM and Judge AR (2008). Hsp70 overexpression inhibits NF-κB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy. FASEB J 22, 3836-3845.
75. Shiao T, Fond A, Deng B, Wehling-Henricks M, Adams ME, Froehner SC and Tidball JG (2004). Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking α- and β1-syntrophins. Hum Mol Genet 13, 1873-1884.
76. Skrabek RQ and Anderson JE (2001). Metabolic shifts and myocyte hypertrophy in deflazacort treatment of mdx mouse cardiomyopathy. Muscle Nerve 24, 192-202.
77. Smith LW, Smith JD and Criswell DS (2002). Involvement of nitric oxide synthase in skeletal muscle adaptation to chronic overload. J Appl Physiol 92, 2005-2011.
78. Song W, Kwak HB and Lawler JM (2009). Exercise training modulates the NOS profile in skeletal muscle from old rats. J Gerontol Ser A Biol Sci Med Sci 64, 540-549.
79. Spencer MJ and Tidball JG (2001). Do immune cells promote the pathology of dystrophin-deficient myopathies? Neuromuscul Disord 11, 556-564.
80. Spurney CF, Knoblach S, Pistilli EE, Nagaraju K, Martin GR and Hoffman EP (2008). Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart. Neuromuscul Disord 18, 371-381.
81. Stern LZ, Ringel SP, Ziter FA, Menander-Huber KB, Ionasescu V, Pellegrino RJ and Snyder RD (1982). Drug trial of superoxide dismutase in Duchenne's muscular dystrophy. Arch Neurol 39, 342-346.
82. Stern LZ, Ringel SP, Ziter FA, Menander-Huber KB, Ionasescu V, Pellegrino RJ, Snyder RD (1982). Drug trial of superoxide dismutase in Duchenne's muscular dystrophy. Arch Neurol 39, 342-346.
83. Stevens ED and Faulkner JA (2000). The capacity of the mdx mouse diaphragm muscle to do oscillatory work. J Physiol 522, 457-466.
84. Sunada Y, Ohi H, Hase A, Ohi H, Hosono T, Arata S et al (2001). Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity. Hum Mol Gen 10, 173-178.
85. Sussman M (2002). Duchenne muscular dystrophy. J Amer Acad Orthoped Surg 10, 138-151.
86. Suzuki N, Motohashi N, Uezumi A, Fukada S, Yoshimura T, Itoyama Y et al (2007). NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest 117, 2468-2476.
87. Suzuki N, Motohashi N, Uezumi A, Fukada S, Yoshimura T, Itoyama Y, Aoki M, Miyagoe Suzuki Y and Takeda S (2007). NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest 117, 2468-2476.
88. Tarnopolsky MA, Mahoney DJ, Vaisar J, Rodriguez C, Doherty TJ, Roy BD and Biggar D (2004). Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology 62, 1771-1777.
89. Tidball JG and Wehling-Henricks M (2004). Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Mol Genet Metab 82, 312-320.
90. Tidball JG and Wehling-Henricks M (2007). The role of free radicals in the pathophysiology of muscular dystrophy. J Appl Physiol 102, 1677-1686.
91. Tkatchenko AV, Le Cam G, Leger JJ and Dechesne CV (2000). Large-scale analysis of differential gene expression in hindlimb muscle and diaphragm of mdx mouse. Biochim Biophys Acta 1500, 17-30.
92. Ushio-Fukai M (2009). Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 11, 1289-1299.
93. Van Gammeren D, Betters JL, Shanely RA, Falk DJ, DeRuisseau KC, Powers SK and Criswell DS (2004). Trolox attenuates mechanical ventilation-induced contractile dysfunction and proteasome activity of the diaphragm. FASEB J 18, A746.
94. Vasilaki A, Mansouri A, Van Remmen H, Van der Meulen JH, Larkin L, Richardson AG et al (2006). Free radical generation by skeletal muscle of adult and old mice: effect of contractile function. Aging Cell 5, 109-117.
95. Venema VJ, Ju H, Zou R, Venema RC (1997). Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 272, 28187-28190.
96. Walton JN and Nattrass FJ (1954). On the classification, natural history and treatment of the myopathies. Brain 77, 169-231.
97. Warren GL, Hayes DA, Lowe DA, Prior BM and Armstrong RB (1993). Materials fatigue initiates eccentric contraction-induced injury in rat soleus muscle. J Physiol 464, 477-488.
98. Watanabe N (2001). Clinical significance of measurement of circulating tumor necrosis factor. Jap J Clin Pathol 49, 829-833.
99. Wehling M, Spencer MJ and Tidball JG (2001). A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 155, 123-131.
100. Whitehead NP, Pham C, Gervasio OL and Allen DG (2008). N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 586, 2003-2014.
101. Whitehead NP, Streamer M, Lusambili LI, Sachs F and Allen DG (2006). Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice. Neuromuscul Disord 16, 845-854.
102. Whitehead NP, Yeung EW, Froehner SC and Allen DG (2010). Skeletal muscle NADPH oxidase is increased and triggers stretch-induced damage in the mdx mouse. PLoS One 5, e15354.
103. Williams IA and Allen DG (2007). The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 293, H1969-H1977.
104. Yang B, Jung D, Motto D, Meyer J, Koretzky G and Campbell KP (1995). SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem 270L, 11711-11714.